In response to frequently asked questions, the Centers for Medicare & Medicaid Services yesterday encouraged health insurers to relax otherwise applicable utilization management processes, as permitted by state law, to ensure that staff at hospitals, clinics and pharmacies can focus their limited time and resources on care delivery, and patients can receive needed care without delay.

The agency also encouraged insurers to work with out-of-network providers to agree upon a rate to ensure that enrollees are not balance billed, noting that enrollees may not be able to access treatment by an in-network provider during the emergency, and to consider additional administrative flexibilities as the public health emergency continues.

With respect to formulary drugs prescribed for off-label use to treat COVID-19, CMS said insurers may wish to apply utilization management practices to prevent shortages and ensure access to all who may benefit. Issuers also should ensure that any changes to prior authorization and utilization management are clinically based and applied in a non-discriminatory manner, and remain compliant with applicable essential health benefit regulations, the agency said.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…